Iovance Biotherapeutics Inc IOVA 深 滬
等待開盤 08-06 09:30:00 美东时间
2.75
-0.080
-2.83%
華盛通- 最 高2.84
- 今 開2.80
- 成交量 817.04万股
- 最 低 2.70
- 昨 收 2.83
- 總市值 9.19亿
- 52周最高 12.505
- 市盈率 靜 --
- 換手率 2.45%
- 52周最低 1.6385
- 委 比 -44.41%
- 總股本 3.34亿
- 歷史最高 54.208
- 量 比 0.53
- 振 幅 4.95%
- 歷史最低 1.6385
- 每 手 1
- 風險率 3.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What to Expect from Ardelyx's Earnings
Ardelyx (NASDAQ:ARDX) is gearing up to announce its quarterly earnings on Monda...
08-02 04:01
美股周涨跌榜 | 本周飙升568%！Abivax S.A.新药III期研究成功；CRO股Medpace周涨超43%
本周飙升568%！生物技术公司Abivax S.A.溃疡性结肠炎口服药物III期研究成功；CRO股Medpace周涨超43%，Q2营收和EBITDA均超预期>>
07-26 10:23
Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
Iovance Biotherapeutics, Inc. will report its Q2 and H1 2025 financial results on August 7, 2025, and host a conference call at 4:30 p.m. ET. Management will discuss the results and provide updates. The webcast can be accessed via the provided link or the Investors section of the company's website. Iovance specializes in developing polyclonal tumor infiltrating lymphocyte (TIL) therapies, with Amtagvi® as the first FDA-approved T cell therapy for...
07-24 20:05
美股牛股 | 肠炎新药临床试验进展积极，ABVX飙涨超580%！ANEB大涨超80%
肠炎新药临床试验进展积极，ABVX飙涨超580%！公司宣布高溢价私有化计划，ANEB大涨超80%>>
07-24 19:53
Analyst Expectations For Iovance Biotherapeutics's Future
During the last three months, 7 analysts shared their evaluations of Iovance Bi...
07-23 20:02
Chardan Capital Maintains Buy on Iovance Biotherapeutics, Maintains $25 Price Target
Chardan Capital analyst Geulah Livshits maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and maintains $25 price target.
07-23 18:12
美股牛股 | 财报大超华尔街预期，CRO公司Medpace飙涨近55%！法拉第未来大涨超43%
财报大超华尔街预期，CRO公司Medpace飙涨近55%！公司获高额预订单，法拉第未来大涨超43%；"Meme股"获散户持续热炒，柯尔百货涨超37%>
07-23 19:34
Iovance climbs after FDA rejection for Replimune’s skin cancer drug
The FDA’s decision to reject Replimune’s (NASDAQ:REPL) lead asset RP1 for a type of skin cancer known as melanoma appears to have boosted its rival, Iovance Biotherapeutics (NASDAQ:IOVA), whose lead p...
07-22 22:54
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Nasdaq Composite falling around 100 points on ...
07-22 22:23
100倍潜力股？Opendoor股价触底疯涨500%，如何在暴涨前寻找下一只“Meme股”黑马？
散户蜂拥晒单买入，投资大佬Jackson建仓看涨Opendoor至82美元！作为普通投资者，如何在暴涨前寻找下一只“Meme股”黑马？>>
07-22 14:34
